Expanding the scope of human DNA polymerase and inhibitors

ACS Chemical Biology

Volumn 9, Issue 1, 2014, Pages 282-290

  Strittmatter, Tobias ^a   Brockmann, Anette ^a   Pott, Moritz ^a   Hantusch, Annika ^a   Brunner, Thomas ^a   Marx, Andreas ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED DNA POLYMERASE BETA; DNA DIRECTED DNA POLYMERASE BETA LAMBDA; DNA POLYMERASE BETA INHIBITOR; DNA POLYMERASE LAMBDA INHIBITOR; HYDROGEN PEROXIDE; MOLECULAR SCAFFOLD; NUCLEOTIDYLTRANSFERASE INHIBITOR; RHODANINE; SMALL MOLECULE INHIBITOR; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLOGICAL FUNCTIONS; CACO 2 CELL LINE; CANCER CELL; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA SYNTHESIS INHIBITION; DRUG POTENCY; DRUG SYNTHESIS; DRUG TARGETING; GENOTOXICITY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

CACO-2 CELLS; COLORECTAL NEOPLASMS; DNA POLYMERASE BETA; DRUG DISCOVERY; ENZYME INHIBITORS; HUMANS; MODELS, MOLECULAR; RHODANINE;

EID: 84896832328     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb4007562     Document Type: Article

References (59)

1. Scharer, O. D. (2003) Chemistry and biology of DNA repair. Angew. Chem., Int. Ed. 42, 2946-2974. (Pubitemid 36903177)
2. Maga, G., and Hubscher, U. (2008) Repair and translesion DNA polymerases as anticancer drug targets. Anti-Cancer Agents Med. Chem. 8, 431-447. (Pubitemid 351761428)
3. Lange, S. S., Takata, K.-i., and Wood, R. D. (2011) DNA polymerases and cancer. Nat. Rev. Cancer 11, 96-110.
4. Loeb, L. A., and Monnat, R. J., Jr. (2008) DNA polymerases and human disease. Nat. Rev. Genet. 9, 594-604.
5. Hubscher, U., Spadari, S., Villani, G., and Maga, G. (2010) DNA Polymerases: Discovery, Characterization and Functions in Cellular DNA Transactions; World Scientific: Singapore. (6) Mayer, T. U. (2003) Chemical genetics: Tailoring tools for cell biology. Trends Cell Biol. 13, 270-277.
6. Florian, S., Hummer, S., Catarinella, M., and Mayer, T. U. (2007) Chemical genetics: Reshaping biology through chemistry. HFSP J. 1, 104-114.
7. Chang, L. M. S., and Bollum, F. J. (1971) Low molecular weight deoxyribonucleic acid polymerase in mammalian cells. J. Biol. Chem. 246, 5835-5837.
8. Garcia-Diaz, M., Dominguez, O., Lopez-Fernandez, L. A., de Lera, L. T., Saniger, M. L., Ruiz, J. F., Parraga, M., Garcia-Ortiz, M. J., Kirchhoff, T., del Mazo, J., Bernad, A., and Blanco, L. (2000) DNA polymerase lambda (Pol lambda), a novel eukaryotic DNA polymerase with a potential role in meiosis. J. Mol. Biol. 301, 851-867.
9. Garcia-Diaz, M., Bebenek, K., Krahn, J. M., Kunkel, T. A., and Pedersen, L. C. (2005) A closed conformation for the Pol lambda catalytic cycle. Nat. Struct. Mol. Biol. 12, 97-98. (Pubitemid 40082923)
10. Almeida, K. H., and Sobol, R. W. (2007) A unified view of base excision repair: Lesion-dependent protein complexes regulated by post-translational modification. DNA Repair (Amst) 6, 695-711. (Pubitemid 46670095)
11. Barakat, K., Gajewski, M., and A. Tuszynski, J. (2012) DNA repair inhibitors: The next major step to improve cancer therapy. Curr. Top. Med. Chem. 12, 1376-1390.
12. Blanca, G., Villani, G., Shevelev, I., Ramadan, K., Spadari, S., Hubscher, U., and Maga, G. (2004) Human DNA polymerases and show different efficiencies of translesion DNA synthesis past abasic sites and alternative mechanisms for frameshift generation. Biochemistry 43, 11605-11615. (Pubitemid 39186982)
13. Boudsocq, F., Benaim, P., Canitrot, Y., Knibiehler, M., Ausseil, F., Capp, J. P., Bieth, A., Long, C., David, B., Shevelev, I., Frierich-Heinecken, E., Hubscher, U., Amalric, F., Massiot, G., Hoffmann, J. S., and Cazaux, C. (2005) Modulation of cellular response to cisplatin by a novel inhibitor of DNA polymerase . Mol. Pharmacol. 67, 1485-1492. (Pubitemid 40594147)
14. Garcia-Diaz, M., Bebenek, K., Kunkel, T. A., and Blanco, L. (2001) Identification of an intrinsic 5-deoxyribose-5-phosphate lyase activity in human DNA polymerase . J. Biol. Chem. 276, 34659-34663.
15. Shimazaki, N., Yoshida, K., Kobayashi, T., Toji, S., Tamai, K., and Koiwai, O. (2002) Over-expression of human DNA polymerase lambda in E. coli and characterization of the recombinant enzyme. Genes Cells 7, 639-651. (Pubitemid 34814756)
16. Ramadan, K., Shevelev, I. V., Maga, G., and Hubscher, U. (2002) DNA polymerase lambda from calf thymus preferentially replicates damaged DNA. J. Biol. Chem. 277, 18454-18458. (Pubitemid 34952392)
17. Ramadan, K., Maga, G., Shevelev, I. V., Villani, G., Blanco, L., and Hubscher, U. (2003) Human DNA polymerase lambda possesses terminal deoxyribonucleotidyl transferase activity and can elongate RNA primers: Implications for novel functions. J. Mol. Biol. 328, 63-72. (Pubitemid 36390280)
18. Ramadan, K., Shevelev, I., and Hubscher, U. (2004) The DNApolymerase-X family: Controllers of DNA quality Nat. Rev. Mol. Cell. Biol. 5, 1038-1043. (Pubitemid 39611539)
19. Lee, J. W., Blanco, L., Zhou, T., Garcia-Diaz, M., Bebenek, K., Kunkel, T. A., Wang, Z., and Povirk, L. F. (2004) Implication of DNA polymerase lambda in alignment-based gap filling for nonhomologous DNA end joining in human nuclear extracts. J. Biol. Chem. 279, 805-811. (Pubitemid 38044887)
20. Nick McElhinny, S. A., Havener, J. M., Garcia-Diaz, M., Juarez, R., Bebenek, K., Kee, B. L., Blanco, L., Kunkel, T. A., and Ramsden, D. A. (2005) A gradient of template dependence defines distinct biological roles for family X polymerases in nonhomologous end joining. Mol. Cell 19, 357-366. (Pubitemid 41074891)
21. Picher, A. J., and Blanco, L. (2007) Human DNA polymerase lambda is a proficient extender of primer ends paired to 7,8-dihydro-8-oxoguanine. DNA Repair 6, 1749-1756. (Pubitemid 350052726)
22. Maga, G., Villani, G., Crespan, E., Wimmer, U., Ferrari, E., Bertocci, B., and Hubscher, U. (2007) 8-Oxo-guanine bypass by human DNA polymerases in the presence of auxiliary proteins. Nature 447, 606-608. (Pubitemid 46868042)
23. van Loon, B., and Hubscher, U. (2009) An 8-oxo-guanine repair pathway coordinated by MUTYH glycosylase and DNA polymerase lambda. Proc. Natl. Acad. Sci. U. S. A. 106, 18201-18206.
24. Markkanen, E., van Loon, B., Ferrari, E., Parsons, J. L., Dianov, G. L., and Hubscher, U. (2012) Regulation of oxidative DNA damage repair by DNA polymerase lambda and MutYH by cross-talk of phosphorylation and ubiquitination. Proc. Natl. Acad. Sci. U. S. A. 109, 437-442.
25. Braithwaite, E. K., Kedar, P. S., Stumpo, D. J., Bertocci, B., Freedman, J. H., Samson, L. D., and Wilson, S. H. (2010) DNA polymerases and mediate overlapping and independent roles in base excision repair in mouse embryonic fibroblasts. PLoS One 5, No. e12229.
26. Zucca, E., Bertoletti, F., Wimmer, U., Ferrari, E., Mazzini, G., Khoronenkova, S., Grosse, N., van Loon, B., Dianov, G., Hubscher, U., and Maga, G. (2013) Silencing of human DNA polymerase lambda causes replication stress and is synthetically lethal with an impaired S phase checkpoint. Nucleic Acids Res. 41, 229-241.
27. Albertella, M. R., Lau, A., and OConnor, M. J. (2005) The overexpression of specialized DNA polymerases in cancer. DNA Repair 4, 583-593. (Pubitemid 40462046)
28. Fu, D., Calvo, J. A., and Samson, L. D. (2012) Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat. Rev. Cancer 12, 104-120.
29. Summerer, D., and Marx, A. (2002) A molecular beacon for quantitative monitoring of the DNA polymerase reaction in real-time. Angew. Chem., Int. Ed. 41, 3620-3622. (Pubitemid 35190466)
30. Locatelli, G. A., Di Santo, R., Crespan, E., Costi, R., Roux, A., Hubscher, U., Shevelev, I., Blanca, G., Villani, G., Spadari, S., and Maga, G. (2005) Diketo hexenoic acid derivatives are novel selective non-nucleoside inhibitors of mammalian terminal deoxynucleotidyl transferases, with potent cytotoxic effect against leukemic cells. Mol. Pharmacol. 68, 538-550. (Pubitemid 41058317)
31. Strittmatter, T., Bareth, B., Immel, T. A., Huhn, T., Mayer, T. U., and Marx, A. (2011) Small molecule inhibitors of human DNA polymerase ?. ACS Chem. Biol. 6, 314-319.
32. Jaiswal, A. S., Banerjee, S., Aneja, R., Sarkar, F. H., Ostrov, D. A., and Narayan, S. (2011) DNA polymerase ? as a novel target for chemotherapeutic intervention of colorectal cancer. PLoS One 6, No. e16691.
33. Coggins, G. E., Maddukuri, L., Penthala, N. R., Hartman, J. H., Eddy, S., Ketkar, A., Crooks, P. A., and Eoff, R. L. (2013) N-Aroyl indole thiobarbituric acids as inhibitors of DNA repair and replication stress response polymerases. ACS Chem. Biol. 8, 1722-1729.
34. Tomasic, T., and Masic, L. P. (2009) Rhodanine as a privileged scaffold in drug discovery. Curr. Med. Chem. 16, 1596-1629.
35. Welsch, M. E., Snyder, S. A., and Stockwell, B. R. (2010) Privileged scaffolds for library design and drug discovery. Curr. Opin. Chem. Biol. 14, 347-361.
36. Mendgen, T., Steuer, C., and Klein, C. D. (2012) Privileged scaffolds or promiscuous binders: A comparative study on rhodanines and related heterocycles in medicinal chemistry. J. Med. Chem. 55, 743-753.
37. Toma, T., Peterlin, M.,(2012) Rhodanine as a scaffold in drug discovery: A critical review of its biological activities and mechanisms of target modulation. Expert Opin. Drug Discovery 7, 549-560.
38. Mizushina, Y., Saito, A., Tanaka, A., Nakajima, N., Kuriyama, I., Takemura, M., Takeuchi, T., Sugawara, F., and Yoshida, H. (2005) Structural analysis of catechin derivatives as mammalian DNA polymerase inhibitors. Biochem. Biophys. Res. Commun. 333, 101-109. (Pubitemid 40813452)
39. Mu?ller, J., Sidler, D., Nachbur, U., Wastling, J., Brunner, T., and Hemphill, A. (2008) Thiazolides inhibit growth and induce glutathione-S- transferase Pi (GSTP1)-dependent cell death in human colon cancer cells. Int. J. Cancer 123, 1797-1806.
40. Martin, S. A., McCabe, N., Mullarkey, M., Cummins, R., Burgess, D. J., Nakabeppu, Y., Oka, S., Kay, E., Lord, C. J., and Ashworth, A. (2010) DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1. Cancer Cell 17, 235-248.
41. Sidler, D., Brockmann, A., Mueller, J., Nachbur, U., Corazza, N., Renzulli, P., Hemphill, A., and Brunner, T. (2012) Thiazolide-induced apoptosis in colorectal cancer cells is mediated via the Jun kinase-Bim axis and reveals glutathione-S-transferase P1 as Achilles heel. Oncogene 31, 4095-4106.
42. Ladduwahetty, T., Gilligan, M., Humphries, A., Merchant, K. J., Fish, R., McAlister, G., Ivarsson, M., Dominguez, M., OConnor, D., and MacLeod, A. M. (2010) Non-basic ligands for aminergic GPCRs: The discovery and development diaryl sulfones as selective, orally bioavailable 5-HT2A receptor antagonists for the treatment of sleep disorders. Bioorg. Med. Chem. Lett. 20, 3708-3712.
43. Ishida, T., In, Y., Inoue, M., Ueno, Y., Tanaka, C., and Hamanaka, N. (1989) Structural elucidation of epalrestat(ONO-2235), a potent aldose reductase inhibitor, and isomerization of its double bonds. Tetrahedron Lett. 30, 959-962. (Pubitemid 19068970)
44. Xia, Z., Knaak, C., Ma, J., Beharry, Z. M., McInnes, C., Wang, W., Kraft, A. S., and Smith, C. D. (2009) Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases. J. Med. Chem. 52, 74-86.
45. Anderluh, M., Jukič M., and Petrič R. (2009) Threecomponent one-pot synthetic route to 2-amino-5-alkylidene-thiazol-4-ones. Tetrahedron 65, 344-350.
46. Vickers, C. J., Gonzalez-Paez, G. E., Umotoy, J. C., Cayanan-Garrett, C., Brown, S. J., and Wolan, D. W. (2013) Small-molecule procaspase activators identified using fluorescence polarization. ChemBioChem 14, 1419-1422.
47. Tomašič, T., Zidar, N., Kovač A., Turk, S., Simcič M., Blanot, D., Muller-Premru, M., Filipič M., Grdadolnik, S. G., Zega, A., Anderluh, M., Gobec, S., Kikelj, D., and Peterlin Mašič L. (2010) 5-Benzylidenethiazolidin-4-ones as multitarget inhibitors of bacterial Mur ligases. ChemMedChem 5, 286-295.
48. Zidar, N., Tomašič, T., šink, R., Rupnik, V., Kovač A., Turk, S., Patin, D., Blanot, D., Contreras Martel, C., Dessen, A. a., Muller Premru, M., Zega, A., Gobec, S., Peterlin Mašič L., and Kikelj, D. (2010) Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD ligase. J. Med. Chem. 53, 6584-6594.
49. Unangst, P. C., Connor, D. T., Cetenko, W. A., Sorenson, R. J., Kostlan, C. R., Sircar, J. C., Wright, C. D., Schrier, D. J., and Dyer, R. D. (1994) Synthesis and biological evaluation of 5-[[3,5-bis(1,1-dimethylethyl)-4- hydroxyphenyl]methylene]oxazoles, -thiazoles, and -imidazoles: novel dual 5-lipoxygenase and cyclooxygenase inhibitors with antiinflammatory activity. J. Med. Chem. 37, 322-328. (Pubitemid 24063052)
50. Kottakota, S. K., Benton, M., Evangelopoulos, D., Guzman, J. D., Bhakta, S., McHugh, T. D., Gray, M., Groundwater, P. W., Marrs, E. C. L., Perry, J. D., and Harburn, J. J. (2012) Versatile routes to marine sponge metabolites through benzylidene rhodanines. Org. Lett. 14, 6310-6313.
51. Nakamura, K., Fujii, M., Ohno, A., and Oka, S. (1984) NAD(P)+-NAD(P)H model. 52. Reduction of olefins by hantzsch ester on silica gel. Tetrahedron Lett. 25, 3983-3986.
52. Maga, G., Ramadan, K., Locatelli, G. A., Shevelev, I., Spadari, S., and Hubscher, U. (2005) DNA elongation by the human DNA polymerase lambda polymerase and terminal transferase activities are differentially coordinated by proliferating cell nuclear antigen and replication protein A. J. Biol. Chem. 280, 1971-1981.
53. Ramadan, K., Shevelev, I. V., Maga, G., and Hubscher, U. (2004) De novo DNA synthesis by human DNA polymerase lambda, DNA polymerase mu and terminal deoxyribonucleotidyl transferase. J. Mol. Biol. 339, 395-404. (Pubitemid 38596957)
54. Ma, J., Starck, S. R., and Hecht, S. M. (1999) DNA polymerase ? inhibitors from Tetracera boiviniana. J. Nat. Prod. 62, 1660-1663. (Pubitemid 30030609)
55. Gao, Z., Maloney, D. J., Dedkova, L. M., and Hecht, S. M. (2008) Inhibitors of DNA polymerase ?: Activity and mechanism. Bioorg. Med. Chem. 16, 4331-4340. (Pubitemid 351539042)
56. Ogawa, A., Murate, T., Suzuki, M., Nimura, Y., and Yoshida, S. (1998) Lithocholic acid, a putative tumor promoter, inhibits mammalian DNA polymerase ?. Cancer Sci. 89, 1154-1159. (Pubitemid 29007996)
57. Corazza, N., Jakob, S., Schaer, C., Frese, S., Keogh, A., Stroka, D., Kassahn, D., Torgler, R., Mueller, C., Schneider, P., and Brunner, T. (2006) TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality. J. Clin. Invest. 116, 2493-2499. (Pubitemid 44330148)
58. Zeiger, E., Anderson, B., Haworth, S., Lawlor, T., Mortelmans, K., and Speck, W. (1987) Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. Environ. Mutagen. 9 (Suppl. 9), 1-109.
59. Hotta, N., Akanuma, Y., Kawamori, R., Matsuoka, K., Oka, Y., Shichiri, M., Toyota, T., Nakashima, M., Yoshimura, I., Sakamoto, N., and Shigeta, Y. (2006) Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative aldose reductase inhibitor-diabetes complications trial. Diabetes Care 29, 1538-1544. (Pubitemid 44127578)